137 related articles for article (PubMed ID: 32179638)
1. Bone Marrow Monocytes and Derived Dendritic Cells from Myelodysplastic Patients Have Functional Abnormalities Associated with Defective Response to Bacterial Infection.
Bento LC; Bacal NS; Rocha FA; Severino P; Marti LC
J Immunol; 2020 Apr; 204(8):2098-2109. PubMed ID: 32179638
[TBL] [Abstract][Full Text] [Related]
2. Defective tumor necrosis factor alpha-induced maturation of monocyte-derived dendritic cells in patients with myelodysplastic syndromes.
Micheva I; Thanopoulou E; Michalopoulou S; Karakantza M; Kouraklis-Symeonidis A; Mouzaki A; Zoumbos N
Clin Immunol; 2004 Dec; 113(3):310-7. PubMed ID: 15507396
[TBL] [Abstract][Full Text] [Related]
3. Surface marker abnormalities in myelodysplastic syndromes.
Elghetany MT
Haematologica; 1998 Dec; 83(12):1104-15. PubMed ID: 9949628
[TBL] [Abstract][Full Text] [Related]
4. Natural killer expansion, human leukocyte antigens-E expression and CD14(+) CD56(+) monocytes in a myelodysplastic syndrome patient.
Terrazzano G; Rubino V; Palatucci AT; Giovazzino A; Annunziatella M; Vitagliano O; Alfinito F; Ruggiero G
Eur J Haematol; 2013 Sep; 91(3):265-269. PubMed ID: 23734938
[TBL] [Abstract][Full Text] [Related]
5. Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes.
Van Leeuwen-Kerkhoff N; Westers TM; Poddighe PJ; Povoleri GAM; Timms JA; Kordasti S; De Gruijl TD; Van de Loosdrecht AA
Haematologica; 2022 Mar; 107(3):655-667. PubMed ID: 33567812
[TBL] [Abstract][Full Text] [Related]
6. A case of CD56+ cutaneous aleukaemic granulocytic sarcoma with myelodysplastic syndrome.
Murakami Y; Nagae S; Matsuishi E; Irie K; Furue M
Br J Dermatol; 2000 Sep; 143(3):587-90. PubMed ID: 10971333
[TBL] [Abstract][Full Text] [Related]
7. Monocyte function in patients with myelodysplastic syndrome.
Pollyea DA; Hedin BR; O'Connor BP; Alper S
J Leukoc Biol; 2018 Sep; 104(3):641-647. PubMed ID: 29656609
[TBL] [Abstract][Full Text] [Related]
8. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.
Mann KP; DeCastro CM; Liu J; Moore JO; Bigner SH; Traweek ST
Am J Clin Pathol; 1997 Jun; 107(6):653-60. PubMed ID: 9169661
[TBL] [Abstract][Full Text] [Related]
9. Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40-CD40L interactions with T helper cells.
Meers S; Kasran A; Boon L; Lemmens J; Ravoet C; Boogaerts M; Verhoef G; Verfaillie C; Delforge M
Leukemia; 2007 Dec; 21(12):2411-9. PubMed ID: 17805323
[TBL] [Abstract][Full Text] [Related]
10. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
11. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
12. [The quantity, subsets and expression of costimulatory molecules of circulating dendritic cells in the patients with myelodysplastic syndromes].
Wang HQ; Shao ZH; Xing LM; Fu R; Tu MF; Sun J; Jia HR
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):474-7. PubMed ID: 18072632
[TBL] [Abstract][Full Text] [Related]
13. Monocyte derived dendritic cells have reduced expression of co-stimulatory molecules but are able to stimulate autologous T-cells in patients with MDS.
Davison GM; Novitzky N; Abdulla R
Hematol Oncol Stem Cell Ther; 2013 Jun; 6(2):49-57. PubMed ID: 23714180
[TBL] [Abstract][Full Text] [Related]
14. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS).
Kotsianidis I; Bouchliou I; Nakou E; Spanoudakis E; Margaritis D; Christophoridou AV; Anastasiades A; Tsigalou C; Bourikas G; Karadimitris A; Tsatalas C
Leukemia; 2009 Mar; 23(3):510-8. PubMed ID: 19020538
[TBL] [Abstract][Full Text] [Related]
15. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
16. Marrow cytokine transcripts and the secondary hematologic disorders.
Preisler HD; Gao XZ; Ming T; Li B; Bi S; Devemy E; Loew J; Raza A
Leuk Lymphoma; 1999 Oct; 35(3-4):297-302. PubMed ID: 10706453
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic significance of immunophenotyping of bone marrow cells in myelodysplastic syndrome without an increase of marrow blasts].
Xu J; Zhang W; Liu Y; Wan SG; Sun XJ; Zhao H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1477-81. PubMed ID: 20030930
[TBL] [Abstract][Full Text] [Related]
18. Success in bone marrow failure? Novel therapeutic directions based on the immune environment of myelodysplastic syndromes.
Cull AH; Rauh MJ
J Leukoc Biol; 2017 Aug; 102(2):209-219. PubMed ID: 28596252
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-Derived Macrophages Are Impaired in Myelodysplastic Syndrome.
Han Y; Wang H; Shao Z
J Immunol Res; 2016; 2016():5479013. PubMed ID: 28074192
[No Abstract] [Full Text] [Related]
20. [Subtype and Functional Biomarker Changes of NK Cells in Peripheral Blood of Patients with Myelodysplastic Syndrome].
Xu SJ; Shao ZH; Fu R; Wang HQ; Liu H; Liu CY; Zhang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):832-836. PubMed ID: 28641645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
